RxDoctor Payments DataLook up a doctor →

Bob Wodecki, MD

Rheumatology · Statesville, NCNPI 1649270190

Payments from drug & device makers

$35,393in general payments, 2019–2025

Across 1,926 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$7K
  • Johnson & Johnson$5K
  • AbbVie$4K
  • Pfizer$2K
  • Novartis$2K
  • UCB, Inc.$1K
  • plus $14K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)485$7,376
Johnson & Johnson149$4,897
AbbVie197$4,300
Pfizer163$1,934
Novartis117$1,815
UCB, Inc.113$1,498
ANI Pharmaceuticals, Inc.64$1,487
AstraZeneca(2 entities)47$1,300
GSK65$1,075
Lilly USA, LLC72$924
Mallinckrodt Hospital Products Inc.42$923
Radius Health, Inc.44$851
Boehringer Ingelheim45$806
Genentech USA, Inc.35$694
E.r. Squibb & Sons, L.L.C.36$632
Sanofi25$566
Collegium Pharmaceutical, Inc.27$497
Aurinia Pharma U.S., Inc.19$423
Regeneron Healthcare Solutions, Inc.11$300
Tersera Therapeutics LLC11$268
Fresenius Kabi USA, LLC10$198
Mallinckrodt Enterprises LLC10$192
Kiniksa Pharmaceuticals International, PLC7$138
Sandoz6$135
Scilex Pharmaceuticals Inc.9$133
Bristol Myers Squibb8$131
Medexus Pharma, Inc.16$127
Cardinal Health 110 LLC1$127
Sobi, Inc5$114
Daiichi Sankyo Inc.6$109
Organon7$109
Janssen Scientific Affairs, LLC2$103
Octapharma USA, Inc.5$96
Sanofi-aventis U.S. LLC2$94
Bioventus LLC5$78
Shield Therapeutics Inc5$74
Abbott5$72
Medtronic3$70
Actelion Pharmaceuticals US, Inc.3$60
Saluda Medical Americas, Inc.1$56
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$52
Hikma Pharmaceuticals USA3$41
GRT US Holding, Inc.3$41
Boston Scientific2$39
Biodelivery Sciences International, Inc.3$39
Spinal Simplicity, LLC2$39
MDD US Operations, LLC3$37
Tonix Medicines, Inc.2$31
Bayer2$30
Merck2$28
Eisai Inc.2$28
Esperion Therapeutics, Inc.2$23
Insmed, Inc.1$21
Ultragenyx Pharmaceutical Inc.1$20
Takeda Pharmaceuticals U.S.A., Inc.1$19
Kiniksa Pharmaceuticals, Ltd.1$18
Novo Nordisk1$16
Invivyd Inc1$15
Alkermes, Inc.1$15
Virtus Pharmaceuticals LLC1$14

How this compares

$35,393 in reported general payments places this provider in the 75th percentile of 210 rheumatology providers in North Carolina.

See all rheumatology providers in North Carolina

Medicare billing

Part B allowed, 2024
$3,599,299
Medicare patients
787
Services billed
237,595

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Statesville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →